CAYSTON
Live / Registered — Registered and renewed (as of 17 May 2018)
What this means for you
Registered since 11 Nov 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Nov 2028: the §8 & §9 renewal).
Record
- Serial number
- 78456010
- Registration number
- 3532392
- Mark type
- Word mark
- Filed
- 23 Jul 2004
- Published for opposition
- 28 Jun 2005
- Registered
- 11 Nov 2008
- Current term from
- 11 Nov 2018
- Next maintenance filing
- §8 & §9 renewal, due by 11 Nov 2028 (grace period to 11 May 2029)
- Attorney of record
- Jack Wessel
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and drugs for use in the treatment of infectious diseases and respiratory disorders
Owner
- GILEAD SCIENCES, INC., Foster City, CA, US
- GILEAD SCIENCES, INC., FOSTER CITY, CA, US
- Corus Pharma, Inc., Seattle, WA, US
- Corus Pharma, Inc., Seattle, WA, US
Prosecution history
- 24 Jun 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Jun 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Jun 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Oct 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Oct 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Oct 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Oct 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Oct 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 May 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 17 May 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 17 May 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 17 May 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 May 2018 — TEAS SECTION 8 & 9 RECEIVED
- 11 Nov 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 16 Sept 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED